About Synokem Pharmaceuticals Limited
Data last updated:
Synokem Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 August 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21002DL1983PLC016353. Its GSTIN is 07AAACS1164N1Z8 (Delhi). The company holds 6 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.82 Cr. It was formerly known as Synokem Pharmaceuticals Private Limited. It is led by directors including Abhinav Arora (Managing Director) and Gajanan Mohan Shenoy.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14/486 Basement & Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087.
As per the financials filed for FY 2025, the company reported a revenue of ₹556.24 Cr. For the same year it recorded a net loss of ₹3.28 Cr (net margin -0.6%) and EBITDA of ₹31.9 Cr (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The company has about 363 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand: Synokem Pharma. As per MCA filings, the company has open charges of ₹200 Cr and satisfied charges of ₹14.75 Cr on record. Court records list 83 cases involving the company, including 38 filed by the company and 37 filed against it; 25 cases are pending. The company has 11 deals on record (9 secondary share transfers, 2 funding rounds), with disclosed funding of ₹51.1 Lakh; the latest was in January 2023. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Bliss GVS Pharma Limited with revenue of ₹846.22 Cr. The company has 27 MSME Form 1 returns on record between 2019 and 2024, listing 4,861 overdue payments to 342 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synokempharma.com.
CIN History of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals has one previous CIN (Corporate Identification Number): U34239DL1983PLC016353. The current CIN is U21002DL1983PLC016353, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21002DL1983PLC016353 | Current |
| U34239DL1983PLC016353 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address14/486 Basement & Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals operates one associated brand: Synokem Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic drugs are manufactured by Synokem Pharma in Delhi. | synokempharma.com |
Business Activity of Synokem Pharmaceuticals Limited
The main business activity of Synokem Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synokem Pharmaceuticals Limited FY 2025 filings available
Synokem Pharmaceuticals Limited reported revenue of ₹556.24 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Synokem Pharmaceuticals Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synokem Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹556.24 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31.9 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.28 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synokem Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synokem Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals has 8 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gajanan Mohan Shenoy | Director | 30 Mar 2024 | 2 Years 6 Months | Current |
| Vishal Gupta | Nominee Director | 18 Jan 2023 | 3 Years 9 Months | Current |
| Abhinav Arora Also directs: SPL Packaging Limited Liability Partnership, Kemsyn Lifesciences Private Limited, Synokem Lifesciences Private Limited and 2 more | Managing Director | 01 Jul 2005 | 21 Years 3 Months | Current |
| Thomas Baby | Director | 01 Jul 2019 | 7 Years 3 Months | Current |
| Shubhangi Agarwal Also directs: Synokem Lifesciences Private Limited, Agsa and Associates LLP, Ampl Capital Limited and 4 more | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Dhiraj Poddar Also directs: Dough Hook Artisanal Bakery LLP, Omniactive Health Technologies Limited, Zifo Technologies Private Limited. and 3 more | Nominee Director | 24 Jul 2024 | 2 Years 2 Months | Current |
Peer Comparison of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bliss GVS Pharma Limited Listed | ₹846.22 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Apex Laboratories Private Limited | ₹834.88 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Chennai, Tamil Nadu, India |
| Gufic Biosciences Limited Listed | ₹823.43 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Medinote Distributors Private Limited | ₹819.71 Cr (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Abil Chempharma Private Limited | ₹795.2 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| SMS Pharmaceuticals Limited Listed | ₹788.97 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| Prime Pharmaceuticals Private Limited | ₹783.06 Cr (FY 2025) | •••• | •••• | 131.0% | •••• | Mumbai, Maharashtra, India |
| Windlas Biotech Limited Listed | ₹777.9 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Dehradun, Uttarakhand, India |
| Fourrts (India) Laboratories Private Limited | ₹760.55 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Chennai, Tamil Nadu, India |
| Pritam International Private Limited | ₹758.46 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Synokem Pharmaceuticals Limited this company | ₹556.24 Cr (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Synokem Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited is audited by BSR & Co. LLP for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BSR & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Synokem Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synokem Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2026 | Others | ₹15 Cr | Open |
| 31 Jul 2024 | Axis Bank Limited | ₹22.5 Cr | Open |
| 06 May 2024 | Others | ₹15 Cr | Open |
| 16 Jan 2024 | Others | ₹20 Cr | Open |
| 22 Sep 2023 | Others | ₹115 Cr | Open |
Total charge records: 9 View all charges
Deals & Funding of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited has 11 deals on record (9 secondary share transfers, 2 funding rounds), with disclosed funding of ₹51.1 Lakh; the latest was in January 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2023 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
| Jan 2023 | Secondary share transfer | Undisclosed | Buyer: Ta India 2 Limited Seller: an individual |
| Jan 2023 | Secondary share transfer | Undisclosed | Buyer: Ta India 2 Limited, an individual Seller: 3 individuals |
| Nov 2022 | Secondary share transfer | Undisclosed | Buyer: Abhinav Arora Huf Seller: an individual |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Jagmohan Arora HUF |
Full deal history
All 11 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited has 83 court cases on record: 38 filed by Synokem Pharmaceuticals, 37 filed against it, 8 where it is another party. 25 cases are pending and 58 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 57 | 26 | 19 |
| High courts | 25 | 11 | 6 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 83)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed by the company against Starus Pharmaceuticals Private Limited | Pending |
| District court, West, Delhi | Commercial suit | Filed by the company against Biomi Life Sciences Private Limited | Pending |
| District court, West, Delhi | Criminal case | Filed by the company against Aanchal Holidays Private Limited | Pending |
| District court, West, Delhi | Criminal case | Filed by the company against Aastha Surgimed Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against Life Care Private Limited | Pending |
Full case history
All 83 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited has 27 MSME Form 1 returns on record between 2019 and 2024, listing 4,861 overdue payments to 342 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 342)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| A3a Infotech Private Limited | •••• | •••• | •••• |
| Wetec Engineering | •••• | •••• | •••• |
| Mex Storage Systems Pvt.L | •••• | •••• | •••• |
| Integrated Cooling Solutions Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 27 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited has a workforce of 363 employees as of Oct 08, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals has 3 subsidiary companies. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Kemsyn Lifesciences Private Limited | U21002MH2024PTC435803 | Locked |
| Synokem Lifesciences Private Limited | U24230DL2020PTC362777 | Locked |
| Nitin Lifesciences Limited | U73100HP2005PLC028049 | Locked |
Showing major subsidiaries. Total: 3.
Recent Activity on Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals Limited has 24 board changes on record since 2005: 9 appointments and 15 cessations. The latest: Yugal Kishor Chothuram Sikri was appointed as Nominee Director on 31 Jan 2026.
32 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Synokem Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synokem Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals has 6 GST registrations: 3 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACS1164N1Z8 | Delhi | Active | 01 Jul 2017 |
| 07AAACS1164N2Z7 | Delhi | Active | 01 Apr 2025 |
| 05AAACS1164N1ZC | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synokem Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synokem Pharmaceuticals Limited
Synokem Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 August 1983 (43+ years old) and is registered under CIN U21002DL1983PLC016353.
Synokem Pharmaceuticals reported revenue of ₹556.24 Cr for FY 2025.
Synokem Pharmaceuticals has 8 current directors:
- Abhinav Arora - Managing Director
- Gajanan Mohan Shenoy - Director
- Vishal Gupta - Nominee Director
- Thomas Baby - Director
- Shubhangi Agarwal - Director
- Dhiraj Poddar - Nominee Director
- Sanjay Khurana - Director
- Yugal Kishor Chothuram Sikri - Nominee Director
Synokem Pharmaceuticals reported a net loss of ₹3.28 Cr (net margin -0.6%) and EBITDA of ₹31.9 Cr (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synokem Pharmaceuticals is 5% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synokem Pharmaceuticals is 07AAACS1164N1Z8, registered in Delhi. The company has 6 GST registrations in all, of which 3 are active and 3 are cancelled or inactive. Other active GSTINs include 07AAACS1164N2Z7 (Delhi), 05AAACS1164N1ZC (Uttarakhand).
The CIN (Corporate Identification Number) of Synokem Pharmaceuticals is U21002DL1983PLC016353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synokem Pharmaceuticals has 83 court cases on record: 38 filed by the company and 37 filed against it. 25 are pending. Most are in the district courts.
Synokem Pharmaceuticals was incorporated on 18 August 1983, making it 43+ years old. It is registered with the Registrar of Companies, Delhi.
Synokem Pharmaceuticals has 11 deals on record (9 secondary share transfers, 2 funding rounds), with disclosed funding of ₹51.1 Lakh; the latest was in January 2023.
The peers of Synokem Pharmaceuticals by revenue are Bliss GVS Pharma Limited, Apex Laboratories Private Limited, Gufic Biosciences Limited, Medinote Distributors Private Limited, Abil Chempharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Yugal Kishor Chothuram Sikri was appointed as Nominee Director on 31 Jan 2026. Dhiraj Poddar was appointed as Nominee Director on 24 Jul 2024. Gajanan Mohan Shenoy ceased to be Additional Director on 07 Apr 2024. Synokem Pharmaceuticals has 24 board changes on record in total.